Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CELF6 antisense RNA 1 (CELF6-AS1; LOC105370887) is a long noncoding antisense RNA gene located near the CELF6 gene in the human genome[6]. As an antisense lncRNA, its transcript is predicted to be complementary to the mRNA of CELF6, a protein-coding gene involved in RNA splicing and implicated in neuropsychiatric processes[3][4]. Antisense lncRNAs such as CELF6-AS1 typically regulate gene expression through mechanisms including transcriptional interference, chromatin modification, and mRNA stability or translation, either in cis (on the same chromosome near their sense gene) or in trans (at distant genomic sites)[2]. However, there is currently no direct experimental evidence or publication on a specific biological role, disease relevance, or drug interactions for CELF6-AS1 itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CELF6 antisense RNA 1 (CELF6-AS1).